Diabetes Therapy and Drug Delivery Market, Global Outlook and Forecast 2022-2028

March 2022 | 105 pages | ID: D3D83D455C32EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Diabetes Therapy and Drug Delivery in Global, including the following market information:

Global Diabetes Therapy and Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Diabetes Therapy and Drug Delivery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Inhalable Insulin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Diabetes Therapy and Drug Delivery include Abbott Laboratories, Medtronic, Sanofi, Novo Nordisk, MannKind, Enteris BioPharma, Dexcom, Senseonics Holding and Medtech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetes Therapy and Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Diabetes Therapy and Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Diabetes Therapy and Drug Delivery Market Segment Percentages, by Type, 2021 (%)

• Inhalable Insulin
• Oral Insulin
• Insulin Patches
• CGM Systems
• Artificial Pancreas

Global Diabetes Therapy and Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Diabetes Therapy and Drug Delivery Market Segment Percentages, by Application, 2021 (%)

• Diagnostic/Clinics
• ICUs
• Home Healthcare

Global Diabetes Therapy and Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Diabetes Therapy and Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Diabetes Therapy and Drug Delivery revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Diabetes Therapy and Drug Delivery revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• Medtronic
• Sanofi
• Novo Nordisk
• MannKind
• Enteris BioPharma
• Dexcom
• Senseonics Holding
• Medtech
• Johnson & Johnson
• Synertech
• Zosano Pharma
• Relmada Therapeutics
• Eli Lilly
• Transdermal Specialties

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Diabetes Therapy and Drug Delivery Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Diabetes Therapy and Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DIABETES THERAPY AND DRUG DELIVERY OVERALL MARKET SIZE

2.1 Global Diabetes Therapy and Drug Delivery Market Size: 2021 VS 2028
2.2 Global Diabetes Therapy and Drug Delivery Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Diabetes Therapy and Drug Delivery Players in Global Market
3.2 Top Global Diabetes Therapy and Drug Delivery Companies Ranked by Revenue
3.3 Global Diabetes Therapy and Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Diabetes Therapy and Drug Delivery Companies in Global Market, by Revenue in 2021
3.5 Global Companies Diabetes Therapy and Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetes Therapy and Drug Delivery Players in Global Market
  3.6.1 List of Global Tier 1 Diabetes Therapy and Drug Delivery Companies
  3.6.2 List of Global Tier 2 and Tier 3 Diabetes Therapy and Drug Delivery Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Diabetes Therapy and Drug Delivery Market Size Markets, 2021 & 2028
  4.1.2 Inhalable Insulin
  4.1.3 Oral Insulin
  4.1.4 Insulin Patches
  4.1.5 CGM Systems
  4.1.6 Artificial Pancreas
4.2 By Type - Global Diabetes Therapy and Drug Delivery Revenue & Forecasts
  4.2.1 By Type - Global Diabetes Therapy and Drug Delivery Revenue, 2017-2022
  4.2.2 By Type - Global Diabetes Therapy and Drug Delivery Revenue, 2023-2028
  4.2.3 By Type - Global Diabetes Therapy and Drug Delivery Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Diabetes Therapy and Drug Delivery Market Size, 2021 & 2028
  5.1.2 Diagnostic/Clinics
  5.1.3 ICUs
  5.1.4 Home Healthcare
5.2 By Application - Global Diabetes Therapy and Drug Delivery Revenue & Forecasts
  5.2.1 By Application - Global Diabetes Therapy and Drug Delivery Revenue, 2017-2022
  5.2.2 By Application - Global Diabetes Therapy and Drug Delivery Revenue, 2023-2028
  5.2.3 By Application - Global Diabetes Therapy and Drug Delivery Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Diabetes Therapy and Drug Delivery Market Size, 2021 & 2028
6.2 By Region - Global Diabetes Therapy and Drug Delivery Revenue & Forecasts
  6.2.1 By Region - Global Diabetes Therapy and Drug Delivery Revenue, 2017-2022
  6.2.2 By Region - Global Diabetes Therapy and Drug Delivery Revenue, 2023-2028
  6.2.3 By Region - Global Diabetes Therapy and Drug Delivery Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Diabetes Therapy and Drug Delivery Revenue, 2017-2028
  6.3.2 US Diabetes Therapy and Drug Delivery Market Size, 2017-2028
  6.3.3 Canada Diabetes Therapy and Drug Delivery Market Size, 2017-2028
  6.3.4 Mexico Diabetes Therapy and Drug Delivery Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Diabetes Therapy and Drug Delivery Revenue, 2017-2028
  6.4.2 Germany Diabetes Therapy and Drug Delivery Market Size, 2017-2028
  6.4.3 France Diabetes Therapy and Drug Delivery Market Size, 2017-2028
  6.4.4 U.K. Diabetes Therapy and Drug Delivery Market Size, 2017-2028
  6.4.5 Italy Diabetes Therapy and Drug Delivery Market Size, 2017-2028
  6.4.6 Russia Diabetes Therapy and Drug Delivery Market Size, 2017-2028
  6.4.7 Nordic Countries Diabetes Therapy and Drug Delivery Market Size, 2017-2028
  6.4.8 Benelux Diabetes Therapy and Drug Delivery Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Diabetes Therapy and Drug Delivery Revenue, 2017-2028
  6.5.2 China Diabetes Therapy and Drug Delivery Market Size, 2017-2028
  6.5.3 Japan Diabetes Therapy and Drug Delivery Market Size, 2017-2028
  6.5.4 South Korea Diabetes Therapy and Drug Delivery Market Size, 2017-2028
  6.5.5 Southeast Asia Diabetes Therapy and Drug Delivery Market Size, 2017-2028
  6.5.6 India Diabetes Therapy and Drug Delivery Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Diabetes Therapy and Drug Delivery Revenue, 2017-2028
  6.6.2 Brazil Diabetes Therapy and Drug Delivery Market Size, 2017-2028
  6.6.3 Argentina Diabetes Therapy and Drug Delivery Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Diabetes Therapy and Drug Delivery Revenue, 2017-2028
  6.7.2 Turkey Diabetes Therapy and Drug Delivery Market Size, 2017-2028
  6.7.3 Israel Diabetes Therapy and Drug Delivery Market Size, 2017-2028
  6.7.4 Saudi Arabia Diabetes Therapy and Drug Delivery Market Size, 2017-2028
  6.7.5 UAE Diabetes Therapy and Drug Delivery Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Diabetes Therapy and Drug Delivery Major Product Offerings
  7.1.4 Abbott Laboratories Diabetes Therapy and Drug Delivery Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 Medtronic
  7.2.1 Medtronic Corporate Summary
  7.2.2 Medtronic Business Overview
  7.2.3 Medtronic Diabetes Therapy and Drug Delivery Major Product Offerings
  7.2.4 Medtronic Diabetes Therapy and Drug Delivery Revenue in Global Market (2017-2022)
  7.2.5 Medtronic Key News
7.3 Sanofi
  7.3.1 Sanofi Corporate Summary
  7.3.2 Sanofi Business Overview
  7.3.3 Sanofi Diabetes Therapy and Drug Delivery Major Product Offerings
  7.3.4 Sanofi Diabetes Therapy and Drug Delivery Revenue in Global Market (2017-2022)
  7.3.5 Sanofi Key News
7.4 Novo Nordisk
  7.4.1 Novo Nordisk Corporate Summary
  7.4.2 Novo Nordisk Business Overview
  7.4.3 Novo Nordisk Diabetes Therapy and Drug Delivery Major Product Offerings
  7.4.4 Novo Nordisk Diabetes Therapy and Drug Delivery Revenue in Global Market (2017-2022)
  7.4.5 Novo Nordisk Key News
7.5 MannKind
  7.5.1 MannKind Corporate Summary
  7.5.2 MannKind Business Overview
  7.5.3 MannKind Diabetes Therapy and Drug Delivery Major Product Offerings
  7.5.4 MannKind Diabetes Therapy and Drug Delivery Revenue in Global Market (2017-2022)
  7.5.5 MannKind Key News
7.6 Enteris BioPharma
  7.6.1 Enteris BioPharma Corporate Summary
  7.6.2 Enteris BioPharma Business Overview
  7.6.3 Enteris BioPharma Diabetes Therapy and Drug Delivery Major Product Offerings
  7.6.4 Enteris BioPharma Diabetes Therapy and Drug Delivery Revenue in Global Market (2017-2022)
  7.6.5 Enteris BioPharma Key News
7.7 Dexcom
  7.7.1 Dexcom Corporate Summary
  7.7.2 Dexcom Business Overview
  7.7.3 Dexcom Diabetes Therapy and Drug Delivery Major Product Offerings
  7.7.4 Dexcom Diabetes Therapy and Drug Delivery Revenue in Global Market (2017-2022)
  7.7.5 Dexcom Key News
7.8 Senseonics Holding
  7.8.1 Senseonics Holding Corporate Summary
  7.8.2 Senseonics Holding Business Overview
  7.8.3 Senseonics Holding Diabetes Therapy and Drug Delivery Major Product Offerings
  7.8.4 Senseonics Holding Diabetes Therapy and Drug Delivery Revenue in Global Market (2017-2022)
  7.8.5 Senseonics Holding Key News
7.9 Medtech
  7.9.1 Medtech Corporate Summary
  7.9.2 Medtech Business Overview
  7.9.3 Medtech Diabetes Therapy and Drug Delivery Major Product Offerings
  7.9.4 Medtech Diabetes Therapy and Drug Delivery Revenue in Global Market (2017-2022)
  7.9.5 Medtech Key News
7.10 Johnson & Johnson
  7.10.1 Johnson & Johnson Corporate Summary
  7.10.2 Johnson & Johnson Business Overview
  7.10.3 Johnson & Johnson Diabetes Therapy and Drug Delivery Major Product Offerings
  7.10.4 Johnson & Johnson Diabetes Therapy and Drug Delivery Revenue in Global Market (2017-2022)
  7.10.5 Johnson & Johnson Key News
7.11 Synertech
  7.11.1 Synertech Corporate Summary
  7.11.2 Synertech Business Overview
  7.11.3 Synertech Diabetes Therapy and Drug Delivery Major Product Offerings
  7.11.4 Synertech Diabetes Therapy and Drug Delivery Revenue in Global Market (2017-2022)
  7.11.5 Synertech Key News
7.12 Zosano Pharma
  7.12.1 Zosano Pharma Corporate Summary
  7.12.2 Zosano Pharma Business Overview
  7.12.3 Zosano Pharma Diabetes Therapy and Drug Delivery Major Product Offerings
  7.12.4 Zosano Pharma Diabetes Therapy and Drug Delivery Revenue in Global Market (2017-2022)
  7.12.5 Zosano Pharma Key News
7.13 Relmada Therapeutics
  7.13.1 Relmada Therapeutics Corporate Summary
  7.13.2 Relmada Therapeutics Business Overview
  7.13.3 Relmada Therapeutics Diabetes Therapy and Drug Delivery Major Product Offerings
  7.13.4 Relmada Therapeutics Diabetes Therapy and Drug Delivery Revenue in Global Market (2017-2022)
  7.13.5 Relmada Therapeutics Key News
7.14 Eli Lilly
  7.14.1 Eli Lilly Corporate Summary
  7.14.2 Eli Lilly Business Overview
  7.14.3 Eli Lilly Diabetes Therapy and Drug Delivery Major Product Offerings
  7.14.4 Eli Lilly Diabetes Therapy and Drug Delivery Revenue in Global Market (2017-2022)
  7.14.5 Eli Lilly Key News
7.15 Transdermal Specialties
  7.15.1 Transdermal Specialties Corporate Summary
  7.15.2 Transdermal Specialties Business Overview
  7.15.3 Transdermal Specialties Diabetes Therapy and Drug Delivery Major Product Offerings
  7.15.4 Transdermal Specialties Diabetes Therapy and Drug Delivery Revenue in Global Market (2017-2022)
  7.15.5 Transdermal Specialties Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Diabetes Therapy and Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Diabetes Therapy and Drug Delivery Market Drivers in Global Market
Table 3. Diabetes Therapy and Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Diabetes Therapy and Drug Delivery in Global Market
Table 5. Top Diabetes Therapy and Drug Delivery Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Diabetes Therapy and Drug Delivery Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Diabetes Therapy and Drug Delivery Revenue Share by Companies, 2017-2022
Table 8. Global Companies Diabetes Therapy and Drug Delivery Product Type
Table 9. List of Global Tier 1 Diabetes Therapy and Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetes Therapy and Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Diabetes Therapy and Drug Delivery Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Diabetes Therapy and Drug Delivery Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Diabetes Therapy and Drug Delivery Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Diabetes Therapy and Drug Delivery Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Diabetes Therapy and Drug Delivery Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Diabetes Therapy and Drug Delivery Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Diabetes Therapy and Drug Delivery Product Offerings
Table 32. Abbott Laboratories Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 33. Medtronic Corporate Summary
Table 34. Medtronic Diabetes Therapy and Drug Delivery Product Offerings
Table 35. Medtronic Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Diabetes Therapy and Drug Delivery Product Offerings
Table 38. Sanofi Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 39. Novo Nordisk Corporate Summary
Table 40. Novo Nordisk Diabetes Therapy and Drug Delivery Product Offerings
Table 41. Novo Nordisk Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 42. MannKind Corporate Summary
Table 43. MannKind Diabetes Therapy and Drug Delivery Product Offerings
Table 44. MannKind Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 45. Enteris BioPharma Corporate Summary
Table 46. Enteris BioPharma Diabetes Therapy and Drug Delivery Product Offerings
Table 47. Enteris BioPharma Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 48. Dexcom Corporate Summary
Table 49. Dexcom Diabetes Therapy and Drug Delivery Product Offerings
Table 50. Dexcom Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 51. Senseonics Holding Corporate Summary
Table 52. Senseonics Holding Diabetes Therapy and Drug Delivery Product Offerings
Table 53. Senseonics Holding Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 54. Medtech Corporate Summary
Table 55. Medtech Diabetes Therapy and Drug Delivery Product Offerings
Table 56. Medtech Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 57. Johnson & Johnson Corporate Summary
Table 58. Johnson & Johnson Diabetes Therapy and Drug Delivery Product Offerings
Table 59. Johnson & Johnson Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 60. Synertech Corporate Summary
Table 61. Synertech Diabetes Therapy and Drug Delivery Product Offerings
Table 62. Synertech Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 63. Zosano Pharma Corporate Summary
Table 64. Zosano Pharma Diabetes Therapy and Drug Delivery Product Offerings
Table 65. Zosano Pharma Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 66. Relmada Therapeutics Corporate Summary
Table 67. Relmada Therapeutics Diabetes Therapy and Drug Delivery Product Offerings
Table 68. Relmada Therapeutics Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 69. Eli Lilly Corporate Summary
Table 70. Eli Lilly Diabetes Therapy and Drug Delivery Product Offerings
Table 71. Eli Lilly Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 72. Transdermal Specialties Corporate Summary
Table 73. Transdermal Specialties Diabetes Therapy and Drug Delivery Product Offerings
Table 74. Transdermal Specialties Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Diabetes Therapy and Drug Delivery Segment by Type in 2021
Figure 2. Diabetes Therapy and Drug Delivery Segment by Application in 2021
Figure 3. Global Diabetes Therapy and Drug Delivery Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diabetes Therapy and Drug Delivery Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diabetes Therapy and Drug Delivery Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetes Therapy and Drug Delivery Revenue in 2021
Figure 8. By Type - Global Diabetes Therapy and Drug Delivery Revenue Market Share, 2017-2028
Figure 9. By Application - Global Diabetes Therapy and Drug Delivery Revenue Market Share, 2017-2028
Figure 10. By Region - Global Diabetes Therapy and Drug Delivery Revenue Market Share, 2017-2028
Figure 11. By Country - North America Diabetes Therapy and Drug Delivery Revenue Market Share, 2017-2028
Figure 12. US Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Diabetes Therapy and Drug Delivery Revenue Market Share, 2017-2028
Figure 16. Germany Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 17. France Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Diabetes Therapy and Drug Delivery Revenue Market Share, 2017-2028
Figure 24. China Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 28. India Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Diabetes Therapy and Drug Delivery Revenue Market Share, 2017-2028
Figure 30. Brazil Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Diabetes Therapy and Drug Delivery Revenue Market Share, 2017-2028
Figure 33. Turkey Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Medtronic Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novo Nordisk Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. MannKind Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Enteris BioPharma Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Dexcom Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Senseonics Holding Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Medtech Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Johnson & Johnson Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Synertech Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Zosano Pharma Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Relmada Therapeutics Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Eli Lilly Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Transdermal Specialties Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)